Updates from ASH22 on MDS and AML, featuring Lourdes Mendez, MD @AAMDSIF
Updates from ASH22 on MDS and AML, featuring Lourdes Mendez, MD @AAMDSIF
Uploaded April 2026 | Updated September 2026, 22 hours ago
In this webinar, Dr. Lourdes Mendez discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2022 meeting. Research findings are explained along with the potential impact of this research on understanding and treating MDS and AML. This is an advanced scientific presentation. At the end of the presentation, there is a question and answer session.
Updates from ASH22 on MDS and AML, featuring Lourdes Mendez, MDTRANSPLANTATION FOR BONE MARROW FAILUREManaging Low Blood Counts from the 2023 New Haven Patient and Family ConferenceUnderstanding Aplastic Anemia 2021 Winter Patient Family ConferenceHigh-Risk MDS from the 2023 Patient and Family Conference in New Haven, CTTransplantation for Older MDS PatientsLiving With Bone Marrow Failure Diseases - San Antonio PFVCAplastic Anemia and Non-Transplant Therapies from the 3-City Tandem Patient-Family ConferenceAthletes life is turned upside-down by diagnosis of PNH: Evans storyLiving with GVHD, or Graft Versus Host Disease, from the Patient and Family Conference Utah 2023Genetics and MDS (Myelodysplastic Syndromes)AAMDSIF 40th Anniversary Summit: Priorities for Future Research Panel Discussion
AAMDSIF |

Updates from ASH22 on MDS and AML, featuring Lourdes Mendez, MD

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER